Detoxification of Deoxynivalenol by a Soil Bacterium Devosia Mutans 17-2-E-8
Total Page:16
File Type:pdf, Size:1020Kb
Detoxification of Deoxynivalenol by a Soil Bacterium Devosia mutans 17-2-E-8 by Jian Wei He A Thesis presented to The University of Guelph In partial fulfillment of requirements for the degree of Doctor of Philosophy in Environmental Sciences and Toxicology Guelph, Ontario, Canada © Jian Wei He, June 2015 ABSTRACT DETOXIFICATION OF DEOXYNIVALENOL BY A SOIL BACTERIUM DEVOSIA MUTANS 17-2-E-8 Jian Wei He Advisors: University of Guelph, 2015 Professor Greg J. Boland Professor Ting Zhou Professor Paul K. Sibley The mycotoxin deoxynivalenol (DON) remains an important challenge in many regions in the world. Microbial detoxification of DON represents a new approach to treating DON-contaminated grains. A bacterial isolate identified as Devosia mutans 17-2- E-8, which showed a high similarity in 16sRNA gene sequence to the Devosia genus, was isolated from an alfalfa soil sample that was enriched for six weeks with Fusarium graminearum-infested corn. D. mutans 17-2-E-8 was capable of reducing DON concentration in liquid corn meal medium up to 100% after incubation at temperatures ranging from 15-37 ºC, and pH levels ranging from 6-8 for 48-72 h under aerobic conditions. The major transformation product was purified by high-speed countercurrent chromatography (HSCCC), and characterized as 3-epi-DON by liquid chromatography- mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR). A minor product, 3-keto-DON, was also detected in the bacterial incubation medium. The cytotoxicity IC50 values of 3-epi-DON and 3-keto-DON were, respectively, 357 and 3.03 times higher than that of DON based on an MTT bioassay assessing cell viability, and were, respectively, 1181 and 4.54 times higher than that of DON based on a BrdU bioassay assessing DNA synthesis. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no statistically significant differences between the control and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi- DON treatments in body and organ weights, haematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. It was concluded that 3-epi-DON was at least 50 times less toxic than DON in the B6C3F1 mouse. The reduced toxicity was achieved through epimerization by the bacterial isolate, and provides a new DON detoxification pathway. Further investigation will assess practical applications for detoxification by epimerization in treating contaminated feed and food matrices. Keywords: Devosia, mutans, deoxynivalenol (DON), detoxification, epimerization, 3-epi- deoxynivalenol (3-epi-DON), high-speed countercurrent chromatography (HSCCC), cytotoxicity, B6C3F1 mouse ACKNOWLEDGEMENTS I would like to extend my gratitude and appreciation to my Graduate Advisory Committee, Drs. Ting Zhou, Greg J. Boland, Genevieve S. Bondy, Peter M. Scott and Paul Sibley, Comprehensive Examination Committee, Drs. Christopher Young, Herman Boermans and J. Christopher Hall, and Final Examination Committee, Drs. Marc Habash, Mark Sumarah and Kari Dunfield for their trust, wisdom, friendship and patience in helping to guide me through this degree. I have had several large challenges in recent years and sometimes these challenges undermined my sense and self-confidence. Special and sincere thanks to Ting, Greg, Genevieve and Peter for comforting me and leading me through these difficult times. I am very lucky to have you as my professors and friends. Sincere gratitude and thanks go to my friends at Agriculture and Agri-Food Canada, University of Guelph and Health Canada for their tremendous support and encouragements. Special thanks go to Drs. Xianhua Yin, Yousef Hassan, Xiu-Zhen Li, Hai Yu, Rong Cao, Suqin Shao, Honghui Zhu, Ronghua Liu, Zhongying Liu, Jun Gu, Raymond Yang, Don Caldwell, Ms. Cheryl Armstrong and Ms. Laurie Coady. I learned from you that, in order to succeed in science, people have to be passionate about their work. It has been a privilege to learn from you and work with you. I would look back on the time doing this research as the best days of my life. Sparkling ideas always came out from lab meetings in restaurants, solutions to problems could always be found in the cafeteria, and the “fancy high-tech equipment parts” were always waiting for me to pick them up from the basement of the lab. HSCCC produced money. Bacterial colony counting was a game for the brain. Cells in a 96-well plastic culture plate made a nice piece of art. Little mice were cute pets. Thanks to my professors and friends for making the experience so enjoyable and memorable. Finally, a thank-you goes to my family for all their love and support. iv PREFACE Selected contents of the thesis have been previously published in a peer-reviewed journal and patent applications: Chapter 1 He, J., Zhou, T., Young, J.C., Boland, G.J., and Scott, P.M. (2010). Chemical and biological transformations for detoxification of trichothecene mycotoxins in human and animal food chains: A review. Trends in Food Science & Technology, 21: 67-76. Chapters 2, 3, 4 and 5 Zhou, T. and He, J. (2009). Bacterial isolate, methods of isolating bacterial isolates and methods for detoxification of trichothecene mycotoxins. United States Provisional Patent Application No. 61/249,023. Filed October 6, 2009. Zhou, T. and He, J. (2010). Bacterial isolate, methods of isolating bacterial isolates and methods for detoxification of trichothecene mycotoxins. Patent Cooperation Treaty Application No. 61/249,023. Filed October 6, 2010 (international). v Table of Contents ABSTRACT ....................................................................................................................... ii ACKNOWLEDGEMENTS ............................................................................................ iv PREFACE .......................................................................................................................... v LIST OF TABLES ......................................................................................................... viii LIST OF FIGURES ......................................................................................................... ix LIST OF ABBREVIATIONS ........................................................................................ xii CHAPTER 1 ...................................................................................................................... 1 LITERATURE REVIEW ................................................................................................ 1 1.1 General overview .................................................................................................... 1 1.2 Introduction ............................................................................................................. 2 1.3 Occurrence and current management of DON ........................................................ 4 1.3.1 Occurrence of DON ...................................................................................... 5 1.3.2 Current management of DON ....................................................................... 6 1.3.3 DON transformation reactions reported to date ............................................ 7 1.4 Microbial transformation of DON ........................................................................ 10 1.4.1 DON-transforming microorganisms ........................................................... 10 1.4.2 Isolation of DON-transforming microorganisms ........................................ 13 1.5 Chemical analysis and separation of DON and its derivatives ............................. 14 1.5.1 DON and its derivatives .............................................................................. 14 1.5.2 Analytical methods ..................................................................................... 15 1.5.3 Purification methods ................................................................................... 16 1.5.4 Characterization of DON and its derivatives .............................................. 17 1.6 Toxicology of DON and its derivatives ................................................................ 18 1.6.1 Toxicokinetics ............................................................................................. 18 1.6.2 Toxicology of DON .................................................................................... 20 1.6.3 Mechanism of DON toxicity ....................................................................... 23 1.6.4 Toxicology of DON derivatives.................................................................. 25 1.7 Effects of culture conditions and environmental factors that influence DON transformation by microorganisms ....................................................................... 26 1.8 Summary ............................................................................................................... 29 1.9 Thesis objectives ................................................................................................... 30 CHAPTER 2 .................................................................................................................... 31 ISOLATION AND IDENTIFICATION OF A NOVEL DEOXYNIVALENOL- TRANSFORMING BACTERIUM DEVOSIA MUTANS 17-2-E-8 ........................... 31 2.1 Abstract ................................................................................................................